Smital Patil
Overview
Explore the profile of Smital Patil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patil S, Vijayanand S, Menon I, Gomes K, Kale A, Bagwe P, et al.
Pharmaceuticals (Basel)
. 2023 Aug;
16(8).
PMID: 37631046
COVID-19 continues to cause an increase in the number of cases and deaths worldwide. Due to the ever-mutating nature of the virus, frequent vaccination against COVID-19 is anticipated. Most of...
2.
Gomes K, Vijayanand S, Bagwe P, Menon I, Kale A, Patil S, et al.
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37445784
This study focused on developing an influenza vaccine delivered in polymeric nanoparticles (NPs) using dissolving microneedles. We first formulated an influenza extracellular matrix protein 2 virus-like particle (M2e VLP)-loaded with...
3.
Bagwe P, Bajaj L, Menon I, Gomes K, Kale A, Patil S, et al.
Int J Pharm
. 2023 Jun;
642:123182.
PMID: 37369287
There is an alarming rise in the number of gonorrhea cases worldwide. Neisseria gonorrhoeae, the bacteria that causes gonorrhea infection, has gradually developed antimicrobial resistance over the years. To date,...
4.
Menon I, Patil S, Bagwe P, Vijayanand S, Kale A, Gomes K, et al.
Vaccines (Basel)
. 2023 Apr;
11(4).
PMID: 37112778
Respiratory syncytial virus (RSV) is one of the leading causes of bronchiolitis and pneumonia in children ages five years and below. Recent outbreaks of the virus have proven that RSV...
5.
Kale A, Joshi D, Menon I, Bagwe P, Patil S, Vijayanand S, et al.
Vaccines (Basel)
. 2023 Mar;
11(3).
PMID: 36992167
Although the global Zika epidemic in 2015-16 fueled vaccine development efforts, there is no approved Zika vaccine or treatment available to date. Current vaccine platforms in clinical trials are administered...
6.
Vijayanand S, Patil S, Menon I, Gomes K, Kale A, Bagwe P, et al.
Pharmaceutics
. 2023 Mar;
15(3).
PMID: 36986756
SARS-CoV-2, the causal agent of COVID-19, is a contagious respiratory virus that frequently mutates, giving rise to variant strains and leading to reduced vaccine efficacy against the variants. Frequent vaccination...
7.
Kale A, Gaur A, Menon I, Chirmule N, Bagwe P, Jawa R, et al.
J Pharm Sci
. 2023 Feb;
112(5):1345-1350.
PMID: 36736775
Vaccines against SARS-CoV-2 have transformed the course of the COVID-19 pandemic with more than 30 authorizations. More than 2 billion people have been vaccinated with these vaccines developed on very...
8.
Patil S, Vijayanand S, Joshi D, Menon I, Gomes K, Kale A, et al.
Int J Pharm
. 2023 Jan;
632:122583.
PMID: 36610521
The objective of this "proof-of-concept" study was to evaluate the synergistic effect of a subunit microparticulate vaccine and microneedles (MN) assisted vaccine delivery system against a human coronavirus. Here, we...
9.
Vijayanand S, Patil S, Joshi D, Menon I, Gomes K, Kale A, et al.
Vaccines (Basel)
. 2022 Sep;
10(9).
PMID: 36146568
This 'proof-of-concept' study aimed to test the microparticulate vaccine delivery system and a transdermal vaccine administration strategy using dissolving microneedles (MN). For this purpose, we formulated poly(lactic-co-glycolic) acid (PLGA) microparticles...
10.
Kale A, Joshi D, Menon I, Bagwe P, Patil S, Vijayanand S, et al.
Int J Pharm
. 2022 Jul;
624:121975.
PMID: 35787459
Despite the detrimental effects associated with Zika infection, there are no approved treatments or vaccines available. To address the need for a safe and effective vaccine for Zika, we formulated...